L-655-708 | m-entrepreneurship.com

Product Name :
L-655-708

Search keywords :
L-655708

drugId :
null

Target Vo:
Gamma-aminobutyric acid A receptor alpha-5

Target Vo Short Name :
GABRA5

Moa_Name:

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Merck & Co

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:

Termination Status :
Preclinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Erenumab medchemexpress
SATB2 Antibody Protocol
Cyclin E1 Antibody (YA483): Cyclin E1 Antibody (YA483) is a non-conjugated and Rabbit origined monoclonal antibody about 47 kDa, targeting to Cyclin E1. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse.

Author: Betaine hydrochloride

Related Posts